Tanshinone I

Tanshinone I

SCHEMBL3664228

Cc1coc2c1C(=O)C(=O)c1c-2ccc2c(C)cccc12.ClC(Cl)Cl

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.89
HIF1A Q16665 4/20 0.89
EPAS1 Q99814 4/20 0.89
CES1 P23141 4/20 0.89
EED O75530 4/20 0.89
SUZ12 Q15022 4/20 0.89
EZH2 Q15910 4/20 0.89
CES2 O00748 3/20 0.89
MAPT P10636 3/20 0.89
PTPN6 P29350 3/20 0.89
PTPN11 Q06124 3/20 0.89
KDM1A O60341 2/20 0.89
BLM P54132 2/20 0.89
POLB P06746 2/20 0.89
NSD1 Q96L73 2/20 0.89
HDAC6 Q9UBN7 1/20 0.89
NQO1 P15559 4/20 0.52
POR P16435 4/20 0.52
IDO1 P14902 8/20 0.47
MEN1 O00255 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tanshinone I SCHEMBL14993883 0.94 TDP1 (1.00) TDP1HIF1AEPAS1CES1EED
Tanshinone I SCHEMBL244391 0.94 TDP1 (1.00) TDP1HIF1AEPAS1CES1EED
Tanshinone I SCHEMBL2564448 0.93 TDP1 (0.97) TDP1HIF1AEPAS1CES1EED
SCHEMBL29411323 0.85 HIF1A (0.81) TDP1HIF1AEPAS1CES1EED
SCHEMBL16023778 0.85 HIF1A (0.81) TDP1HIF1AEPAS1CES1EED
Isotanshinone Ii SCHEMBL30035659 0.85 HIF1A (0.81) TDP1HIF1AEPAS1CES1EED
Tanshinone I SCHEMBL728081 0.83 EED (0.73) TDP1HIF1AEPAS1CES1EED
SCHEMBL16152288 0.80 TDP1 (0.73) TDP1HIF1AEPAS1CES1EED
SCHEMBL29520853 0.80 TDP1 (0.73) TDP1HIF1AEPAS1CES1EED
SCHEMBL30381335 0.80 EED (0.73) TDP1HIF1AEPAS1CES1EED

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9283256-B2 Antibacterial composition comprising Salvia extracts BOTANIC CENTURY (BEIJING) CO. LTD. (CN) 2016-03-15 US disclosed
US-20100292318-A1 ANTIBACTERIAL COMPOSITION COMPRISING SALVIA EXTRACTS BOTANIC CENTURY (BEIJING) CO. LTD. (CN) 2010-11-18 US disclosed
EP-2211883-A1 ANTIBACTERIAL COMPOSITION COMPRISING SALVIA EXTRACTS Botanic Century (Beijing) Co. Ltd (CN) 2010-08-04 EP disclosed
WO-2009050451-A1 ANTIBACTERIAL COMPOSITION COMPRISING SALVIA EXTRACTS BOTANIC CENTURY (BEIJING) CO. LTD (CN) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292318-A1 ANTIBACTERIAL COMPOSITION COMPRISING SALVIA EXTRACTS SRI, PSD, SRRT TDP1 3857/4885HIF1A 596/4885EPAS1 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.